DILIC
Dai-ichi Life Insurance Company Portfolio holdings
AUM
$3.56B
1-Year Return
26.13%
This Quarter Return
+13.6%
1 Year Return
+26.13%
3 Year Return
+87.23%
5 Year Return
+116.4%
10 Year Return
–
AUM
$4.06B
AUM Growth
+$392M
(+11%)
Cap. Flow
-$65.9M
Cap. Flow
% of AUM
-1.62%
Top 10 Holdings %
Top 10 Hldgs %
25.47%
Holding
531
New
52
Increased
148
Reduced
147
Closed
11
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$197M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$133M |
| 3 |
Idexx Laboratories
IDXX
|
+$14.9M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$10.6M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$9.94M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$152M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$95.1M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$52.9M |
| 4 |
Apple
AAPL
|
+$25.1M |
| 5 |
iShares MSCI All Country Asia ex Japan ETF
AAXJ
|
+$20.6M |
Sector Composition
| 1 | Technology | 14.54% |
| 2 | Financials | 11.97% |
| 3 | Healthcare | 11.52% |
| 4 | Consumer Discretionary | 8.43% |
| 5 | Consumer Staples | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Cigna
CI
$80.8B
| $6.09M | 0.15% |
37,879
| – | – |
|
152
Edwards Lifesciences
EW
$45.5B
| $6.08M | 0.15% |
95,388
-83,658
| -47% | -$5.34M |
|
153
Constellation Brands
STZ
$24.6B
| $6.05M | 0.15% |
34,529
| – | – |
|
154
Veeva Systems
VEEV
$45.3B
| $6.05M | 0.15% |
+47,707
| New | +$6.05M |
|
155
BioMarin Pharmaceuticals
BMRN
$10.4B
| $5.92M | 0.15% |
66,648
+15,509
| +30% | +$1.38M |
|
156
Charles Schwab
SCHW
$170B
| $5.83M | 0.14% |
136,333
| – | – |
|
157
Fidelity National Information Services
FIS
$34.9B
| $5.83M | 0.14% |
51,529
+1,924
| +4% | +$218K |
|
158
F5
FFIV
$18.5B
| $5.83M | 0.14% |
37,124
+1,371
| +4% | +$215K |
|
159
Becton Dickinson
BDX
$53.6B
| $5.77M | 0.14% |
23,664
| – | – |
|
160
Hormel Foods
HRL
$13.8B
| $5.76M | 0.14% |
128,667
+5,010
| +4% | +$224K |
|
161
Keysight
KEYS
$29.3B
| $5.7M | 0.14% |
+65,318
| New | +$5.7M |
|
162
Freeport-McMoran
FCX
$64.2B
| $5.65M | 0.14% |
438,294
+278,514
| +174% | +$3.59M |
|
163
AGNC Investment
AGNC
$10.7B
| $5.53M | 0.14% |
307,272
+11,909
| +4% | +$214K |
|
164
Zebra Technologies
ZBRA
$15.9B
| $5.51M | 0.14% |
26,305
-23,817
| -48% | -$4.99M |
|
165
Elevance Health
ELV
$70.2B
| $5.51M | 0.14% |
19,193
+60
| +0.3% | +$17.2K |
|
166
Biogen
BIIB
$21.2B
| $5.49M | 0.14% |
23,231
+66
| +0.3% | +$15.6K |
|
|
ZEN
167
DELISTED
ZENDESK INC
ZEN
| $5.48M | 0.14% |
64,455
-92,912
| -59% | -$7.9M |
|
168
Boston Scientific
BSX
$152B
| $5.46M | 0.13% |
142,285
-1,694
| -1% | -$65K |
|
169
General Mills
GIS
$26.7B
| $5.43M | 0.13% |
105,007
+2,395
| +2% | +$124K |
|
|
CELG
170
DELISTED
Celgene Corp
CELG
| $5.41M | 0.13% |
57,352
-32,268
| -36% | -$3.04M |
|
171
Chubb
CB
$111B
| $5.41M | 0.13% |
38,609
-14,166
| -27% | -$1.98M |
|
172
Cognizant
CTSH
$33.8B
| $5.36M | 0.13% |
73,988
| – | – |
|
173
Essex Property Trust
ESS
$17.2B
| $5.33M | 0.13% |
18,419
+542
| +3% | +$157K |
|
174
Twilio
TWLO
$15.7B
| $5.32M | 0.13% |
+41,145
| New | +$5.32M |
|
175
Northrop Grumman
NOC
$82.5B
| $5.31M | 0.13% |
19,706
-131
| -0.7% | -$35.3K |
|